Notably, B-Myb knockdown also attenuated the phosphorylation of ERK induced by EGF treatment (Fig. 8d), suggesting that B-Myb is a positive regulator for the activation of ERK and AKT pathways in CRC cells. The gene discussed is MYBL2; the disease is colorectal carcinoma.